Dr. Garrett is Chief Operating Officer / Chief Scientific Officer at AptamiR Therapeutics. Following an accomplished academic career at the University of Adelaide and the University of Texas he held senior positions at Tutume Consulting, Zimmer Biomet, Surgacoll, Elk Biologics and OsteoScreen overseeing drug-device R&D development and operations. Dr Garrett has a PhD in Pathology, MSc in Physiology, BSc in Biochemistry and Organic Chemistry from the University of Adelaide, a degree in Medical Technology from Uni of South Australia and a postgraduate fellowship in Endocrinology at the University of Texas Health Science Center. He currently holds an appointment as Associate Professor at University of Texas.
